These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
555 related items for PubMed ID: 25975262
1. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion. Cai S, Ye Z, Wang X, Pan Y, Weng Y, Lao S, Wei H, Li L. J Exp Clin Cancer Res; 2015 May 15; 34(1):48. PubMed ID: 25975262 [Abstract] [Full Text] [Related]
2. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ. Int J Clin Exp Pathol; 2014 May 15; 7(10):6929-35. PubMed ID: 25400777 [Abstract] [Full Text] [Related]
3. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway. Liu X, Min S, Wu N, Liu H, Wang T, Li W, Shen Y, Zhao C, Wang H, Qian Z, Xu H, Chen Y, Wang X. Cancer Lett; 2019 Apr 10; 447():56-65. PubMed ID: 30685413 [Abstract] [Full Text] [Related]
4. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer. Chen B, Tan Z, Gao J, Wu W, Liu L, Jin W, Cao Y, Zhao S, Zhang W, Qiu Z, Liu D, Mo X, Li W. J Exp Clin Cancer Res; 2015 Oct 21; 34():126. PubMed ID: 26490682 [Abstract] [Full Text] [Related]
5. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells. Li ZF, Yao YD, Zhao YY, Liu Y, Liu ZH, Hu P, Zhu ZR. J Clin Lab Anal; 2020 Sep 21; 34(9):e23362. PubMed ID: 32463132 [Abstract] [Full Text] [Related]
6. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion. Lu W, Xia YH, Qu JJ, He YY, Li BL, Lu C, Luo X, Wan XP. Neoplasma; 2013 Sep 21; 60(5):493-503. PubMed ID: 23790167 [Abstract] [Full Text] [Related]
7. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1. Li X, Ke Q, Li Y, Liu F, Zhu G, Li F. Int J Biochem Cell Biol; 2010 Jan 21; 42(1):70-9. PubMed ID: 19778628 [Abstract] [Full Text] [Related]
8. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells. Li Z, Zhu W, Xiong L, Yu X, Chen X, Lin Q. Oncotarget; 2016 Sep 20; 7(38):61366-61377. PubMed ID: 27542260 [Abstract] [Full Text] [Related]
9. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation. Siu MK, Kong DS, Ngai SY, Chan HY, Jiang L, Wong ES, Liu SS, Chan KK, Ngan HY, Cheung AN. PLoS One; 2015 Sep 20; 10(7):e0133467. PubMed ID: 26218748 [Abstract] [Full Text] [Related]
10. A two kinase-gene signature model using CDK2 and PAK4 expression predicts poor outcome in non-small cell lung cancers. Wang X, Lu Y, Feng W, Chen Q, Guo H, Sun X, Bao Y. Neoplasma; 2016 Sep 20; 63(2):322-9. PubMed ID: 26774155 [Abstract] [Full Text] [Related]
11. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients. Li D, Zhang Y, Li Z, Wang X, Qu X, Liu Y. Tumour Biol; 2015 Dec 20; 36(12):9431-6. PubMed ID: 26124003 [Abstract] [Full Text] [Related]
12. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression. Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H, Mai Z, Guo K, Wang Y, Li S, Chen H, Luo W, Yang Z. Biomed Pharmacother; 2016 Aug 20; 82():290-7. PubMed ID: 27470365 [Abstract] [Full Text] [Related]
13. PAK4 expression is associated with the prognosis in non-small cell lung cancer. Li C, Ji D, Duan A, Jiang Q. Medicine (Baltimore); 2022 Aug 19; 101(33):e30050. PubMed ID: 35984204 [Abstract] [Full Text] [Related]
14. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer. Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, Taniguchi T, Yokoi K, Osada H, Sekido Y. J Surg Res; 2013 Jan 19; 179(1):24-32. PubMed ID: 22985775 [Abstract] [Full Text] [Related]
15. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion. Chen P, Li K, Liang Y, Li L, Zhu X. Exp Lung Res; 2013 Feb 19; 39(1):9-17. PubMed ID: 23215946 [Abstract] [Full Text] [Related]
16. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Zhang HJ, Siu MK, Yeung MC, Jiang LL, Mak VC, Ngan HY, Wong OG, Zhang HQ, Cheung AN. Carcinogenesis; 2011 May 19; 32(5):765-71. PubMed ID: 21325635 [Abstract] [Full Text] [Related]
17. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J, Zhu CQ, Bandarchi B, Wang YH, Navab R, Shepherd FA, Jurisica I, Tsao MS. Clin Cancer Res; 2012 Apr 01; 18(7):1914-24. PubMed ID: 22307136 [Abstract] [Full Text] [Related]
18. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Ahmed T, Shea K, Masters JR, Jones GE, Wells CM. Cell Signal; 2008 Jul 01; 20(7):1320-8. PubMed ID: 18424072 [Abstract] [Full Text] [Related]
19. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway. Wang Z, Luo Z, Zhou L, Li X, Jiang T, Fu E. Cancer Sci; 2015 Oct 01; 106(10):1303-12. PubMed ID: 26212035 [Abstract] [Full Text] [Related]
20. Expression of Ras-related protein 25 predicts chemotherapy resistance and prognosis in advanced non-small cell lung cancer. Ma YF, Yang B, Li J, Zhang T, Guo JT, Chen L, Li M, Chu J, Liang CY, Liu Y. Genet Mol Res; 2015 Oct 30; 14(4):13998-4008. PubMed ID: 26535714 [Abstract] [Full Text] [Related] Page: [Next] [New Search]